Opportunity Information: Apply for PAR 17 019
The National Institute on Aging (NIA), part of the National Institutes of Health (NIH), offered this funding opportunity (PAR-17-019) to support revision applications for currently active, NIA-funded Alzheimer's Disease Core Centers (ADCCs) that operate under the P30 center grant mechanism. The point of the opportunity is not to create brand-new centers, but to allow existing ADCCs to expand what they are already doing by broadening the scope of their funded work. In practical terms, this means a funded ADCC could request additional support to add capabilities, services, or infrastructure that strengthen the center's ability to support Alzheimer's disease and related dementia research.
A revision under this announcement could take the form of proposing an entirely new core within the existing center structure or making substantial modifications to an existing core. "Cores" in a P30 context are shared-resource components that provide services, expertise, tools, data, or other centralized support to multiple research projects and investigators within the center. So the revision could be used to create a new shared-resource component (for example, a new clinical, data, biomarker, imaging, neuropathology, statistics, or outreach-related core) or to significantly enhance a current one, as long as the changes clearly expand the parent award's scope rather than simply maintaining ongoing activities.
A key constraint is that the revision request cannot extend the project beyond the end date of the parent P30 award. In other words, any added work and any added funds requested through the revision must fit within the existing grant's current project period. This makes the revision mechanism a way to accelerate or broaden impact during the remaining time of an active center award rather than a route to renew or extend the center itself.
Eligibility is tightly tied to the status of the parent award and to institutional type. The eligible applicant category listed includes public and state-controlled institutions of higher education, reflecting the typical home institutions for NIH-funded academic research centers. At the same time, the announcement clearly excludes non-U.S. participation as applicants or components: non-domestic (non-U.S.) entities (foreign institutions) cannot apply, non-domestic components of U.S. organizations are not eligible, and foreign components as defined by the NIH Grants Policy Statement are not allowed. The intent is that the revision work be carried out entirely within eligible U.S.-based institutional structures associated with the active NIA-funded P30 center.
From an administrative standpoint, this is a discretionary grant opportunity in the health funding category (CFDA 93.866). The opportunity was created on October 19, 2016, and the original closing date listed is January 7, 2020. The provided source data does not specify an award ceiling or an expected number of awards, which suggests that budgets and award counts would depend on the specifics of submitted revision requests and the availability of funds, consistent with many NIH center-related revision opportunities.
Overall, this FOA was designed to give currently funded NIA Alzheimer's Disease Core Centers a structured way to add new shared resources or substantially strengthen existing cores, thereby increasing the center's research support capacity, while keeping all requested activities within the remaining time and boundaries of the existing P30 award and within U.S.-eligible institutional participation rules.Apply for PAR 17 019
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Revision Requests for Active Alzheimer's Disease Core Centers (P30)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2016-10-19.
- Applicants must submit their applications by 2020-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Public and State controlled institutions of higher education.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Strengthening Independent Media in Bangladesh
Previous opportunity: Emerging Global Leader Award (K43)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 17 019
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 17 019) also looked into and applied for these:
| Funding Opportunity |
|---|
| Aging Research Dissertation Awards to Increase Diversity (R36) Apply for PAR 17 025 Funding Number: PAR 17 025 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Renewal of the Longevity Consortium (U19) Apply for PAR 17 024 Funding Number: PAR 17 024 Agency: National Institutes of Health Category: Health Funding Amount: $6,155,384 |
| Brain Lymphatic System in Aging and Alzheimer's Disease (R01) Apply for RFA AG 17 055 Funding Number: RFA AG 17 055 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Human Cell Biology of Genetic Variants in Alzheimer's Disease (R01) Apply for RFA AG 17 053 Funding Number: RFA AG 17 053 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Systems Biology Approaches to Alzheimers Disease Using Non-mammalian Laboratory Animals (R01) Apply for RFA AG 17 057 Funding Number: RFA AG 17 057 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Dynamic Interactions between Systemic or Non-Neuronal Systems and the Brain in Aging and in Alzheimers Disease (R01) Apply for PAR 17 029 Funding Number: PAR 17 029 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Common Mechanisms and Interactions Among Neurodegenerative Diseases (R01) Apply for PAS 17 028 Funding Number: PAS 17 028 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Role of Age-Associated Metabolic Changes in Alzheimer's Disease (AD) (R01) Apply for PAR 17 031 Funding Number: PAR 17 031 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Exosomes: From Biogenesis and Secretion to the Early Pathogenesis of Alzheimer's Disease (R01) Apply for RFA AG 17 051 Funding Number: RFA AG 17 051 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01) Apply for PAR 17 032 Funding Number: PAR 17 032 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01) Apply for PAR 17 033 Funding Number: PAR 17 033 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44) Apply for PAR 17 035 Funding Number: PAR 17 035 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Multimorbidity in Alzheimers Disease Impacts Choice of Ancillary Treatments (R33) Apply for RFA AG 17 060 Funding Number: RFA AG 17 060 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R01) Apply for PAR 17 038 Funding Number: PAR 17 038 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Platform Delivery Technologies for Nucleic Acid Therapeutics (R41/R42) Apply for PAR 17 036 Funding Number: PAR 17 036 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Multimorbidity in Alzheimers Disease Impacts Choice of Ancillary Treatments (R21/R33) Apply for RFA AG 17 059 Funding Number: RFA AG 17 059 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R21/R33) Apply for PAR 17 037 Funding Number: PAR 17 037 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research Education: Initiative for Maximizing Student Development (IMSD) Program (R25) Apply for PAR 17 040 Funding Number: PAR 17 040 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Focused Technology Research and Development (R01) Apply for PAR 17 045 Funding Number: PAR 17 045 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Exploratory Research for Technology Development (R21) Apply for PAR 17 046 Funding Number: PAR 17 046 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 17 019", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.